Inflammation, metaflammation and immunometabolic disorders
The DOI matches its Crossref record; 144 of the 144 references it cites were found in a registry or an index.
Abstract
Proper regulation and management of energy, substrate diversity and quantity, as well as macromolecular synthesis and breakdown processes, are fundamental to cellular and organismal survival and are paramount to health. Cellular and multicellular organization are defended by the immune response, a robust and critical system through which self is distinguished from non-self, pathogenic signals are recognized and eliminated, and tissue homeostasis is safeguarded. Many layers of evolutionarily conserved interactions occur between immune response and metabolism. Proper maintenance of this delicate balance is crucial for health and has important implications for many pathological states such as obesity, diabetes, and other chronic non-communicable diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hypertrophic visceral adipose tissue is a primary driver of chronic, low-grade meta-inflammation, characterized by an accelerated secretion of pro-inflammatory cytokines (such as TNF-alpha and IL-6) and a concomitant reduction in protective adiponectin [9,11,12].”
From Trimester-Specific Bioelectrical Impedance Reference Curves in Physiological Pregnancy: Mapping Maternal Body Composition and Hydration Trajectories (2026) · cites this paper as [9]
In the citing paper
“Excess visceral adiposity does not merely represent a passive energy reserve; rather, it acts as an active immunometabolic organ [8-10].”
From Trimester-Specific Bioelectrical Impedance Reference Curves in Physiological Pregnancy: Mapping Maternal Body Composition and Hydration Trajectories (2026) · cites this paper as [9]
In the citing paper
“Inflammageing is now being recognized as a hallmark of ageing and a key driver of disease (FIG. 3Aa), including ageing-associated diseases, and has been described as a prominent risk factor for morbidity and death95–97.”
From NAD+ metabolism and its roles in cellular processes during ageing (2021) · cites this paper as [96]
In the citing paper
“Chronic inflammation has profound effects on systemic metabolism, via a complicated crosstalk between immune cells and metabolic cells, such as hepatocytes and adipocytes, influencing metabolic processes such as glucose and lipid uptake, and insulin sensitivity96.”
From NAD+ metabolism and its roles in cellular processes during ageing (2021) · cites this paper as [96]
In the citing paper
“For example, in obese tissues such as the visceral fat, peripheral monocytes are recruited by stressed adipocytes, leading to a progressive infiltration of proinflammatory M1-like macrophages and the displacement of the resident, anti-inflammatory M2 macrophages96.”
From NAD+ metabolism and its roles in cellular processes during ageing (2021) · cites this paper as [96]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Collino, M., Benetti, E., Rogazzo, M., Chiazza, F., Mastrocola, R., Nigro, D., Cutrìn, J. C., Aragno, M., Fantozzi, R., Minetto, M. A., et al. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12888 · Cited by 25
RetractedObesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29881 · Cited by 4,664
Genetic studies of body mass index yield new insights for obesity biology
Study, T. L. C., Locke, A. E., The ADIPOGen Consortium, The AGEN-BMI Working Group, The CARDIOGRAMplusC4D Consortium, The CKDGen Consortium, The, G. L. G. C., The, I. C. B. P., The MAGIC Investigators, The MuTHER Consortium, et al. (2015) · Nature · doi:10.1038/nature14177 · Cited by 4,534
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Cited by
Items 201–300 of 1,004
Obesity-Driven Metabolic Disorders: The Interplay of Inflammation and Mitochondrial Dysfunction
Choi, W., Woo, G. H., Kwon, T., & Jeon, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199715 · Cited by 130
“Pathophysiologically, T2DM is an obesity-driven metabolic disorder where chronic inflammation and metabolic stress work together to trigger and accelerate the disease [46,76].”
Caputo, T., Gilardi, F., & Desvergne, B. (2017) · FEBS Letters · doi:10.1002/1873-3468.12742 · Cited by 122
Prattichizzo, F., Giuliani, A., Mensa’, E., Sabbatinelli, J., Nigris, V. D., Rippo, M. R., Sala, L. L., Procopio, A. D., Olivieri, F., & Ceriello, A. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.10.003 · Cited by 120
Ranneh, Y., Akim, A. M., Hamid, H. A., Khaza’ai, H., Fadel, A., & Mahmoud, A. M. (2019) · Nutrition & Metabolism · doi:10.1186/s12986-019-0341-z · Cited by 126
Gut microbiota and immunity relevance in eubiosis and dysbiosis
Al-Rashidi, H. E. (2022) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2021.10.068 · Cited by 105
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: the biology of a neglected disease
Arron, H. E., Marsh, B. D., Khan, M. A., Jaeger, B., Kell, D., & Pretorius, E. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1386607 · Cited by 140
Adipose tissue inflammation in aging
Mau, T., & Yung, R. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2017.10.014 · Cited by 110
“Adipose tissue inflammation in obesity is also termed ‘metaflammation’ (Hotamisligil, 2017).”
BackgroundGuo, J., Li, D., Tao, H., Li, G., Liu, R., Dou, Y., Jin, T., Li, L., Huang, J., Hu, H., et al. (2019) · Advanced Materials · doi:10.1002/adma.201904607 · Cited by 115
Kjærgaard, K., Mikkelsen, A. C. D., Wernberg, C. W., Grønkjær, L. L., Eriksen, P. L., Damholdt, M. F., Mookerjee, R. P., Vilstrup, H., Lauridsen, M. M., & Thomsen, K. L. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040673 · Cited by 124
Knockdown of ANT2 reduces adipocyte hypoxia and improves insulin resistance in obesity
Seo, J. B., Riopel, M., Cabrales, P., Huh, J. Y., Bandyopadhyay, G. K., Andreyev, A. Y., Murphy, A. N., Beeman, S. C., Smith, G. I., Klein, S., et al. (2018) · Nature Metabolism · doi:10.1038/s42255-018-0003-x · Cited by 112
Therapeutic effects of turmeric in several diseases: An overview
Hay, E., Lucariello, A., Contieri, M., Esposito, T., Luca, A. D., Guerra, G., & Perna, A. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.108729 · Cited by 111
Cellular Senescence in Kidney Fibrosis: Pathologic Significance and Therapeutic Strategies
Xu, J., Zhou, L., & Liu, Y. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.601325 · Cited by 123
“Systemic inflammation increases with age (Goldberg and Dixit, 2015) and is worsened in chronic diseases, such as metabolic syndrome (Hotamisligil, 2017), CKD (Kooman et al., 2017a) and cardiovascular disease (CVD) (Gistera and Hansson, 2017).”
BackgroundAmato, A., Terzo, S., & Mulè, F. (2019) · Antioxidants · doi:10.3390/antiox8120608 · Cited by 107
“, Western diet) have been linked to the development of neurodegeneration [21], depression, and cognitive decline [22,23].”
BackgroundInflammation and its resolution and the musculoskeletal system
Gallo, J., Raška, M., Kriegová, E., & Goodman, S. B. (2017) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2017.05.007 · Cited by 129
“Thus, neutralisation of HMGB1 and/or RAGE receptors should lead to reduced inflammation [51].”
BackgroundPerivascular Adipose Tissue as a Relevant Fat Depot for Cardiovascular Risk in Obesity
Costa, R. M., Neves, K. B., Tostes, R. C., & Lobato, N. S. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00253 · Cited by 107
“Studies in humans and animal models have demonstrated an important upstream role of this protein in integrating inflammatory and metabolic function that were recently reviewed elsewhere (Hotamisligil, 2017).”
BackgroundThe Impact of Adipose Tissue–Derived miRNAs in Metabolic Syndrome, Obesity, and Cancer
Cardoso, G. S. H. R., Corrêa, L. H., & Magalhães, K. G. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.563816 · Cited by 123
Intercellular Transmission of Hepatic ER Stress in Obesity Disrupts Systemic Metabolism
Tirosh, A., Tuncman, G., Calay, E. S., RATHAUS, M., Ron, I., Tirosh, A., Yalçın, A., Lee, Y. G., Livne, R., Ron, S., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.11.009 · Cited by 113
Liot, S., Balas, J., Aubert, A., Prigent, L., Mercier‐Gouy, P., Verrier, B., Bertolino, P., Hennino, A., Valcourt, U., & Lambert, E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.612271 · Cited by 133
“Infiltrating Immune Cells Chronic pancreatitis is a risk factor for the development of PDAC as well as of systemic diseases characterized by chronic low-grade inflammation, such as metaflammation in patients with the metabolic syndrome or diabetes (28, 29).”
BackgroundMetabolic endotoxemia promotes adipose dysfunction and inflammation in human obesity
Clemente‐Postigo, M., Oliva‐Olivera, W., Coín‐Aragüez, L., Ramos‐Molina, B., Giráldez‐Pérez, R. M., Lhamyani, S., Alcaide‐Torres, J., Pérez‐Martínez, P., Bekay, R. E., Cardona, F., et al. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00277.2018 · Cited by 126
Endocrine regulation of immunity in insects
Nunes, C., Sucena, É., & Koyama, T. (2020) · FEBS Journal · doi:10.1111/febs.15581 · Cited by 131
Wu, J., Li, C., Bai, L., Wu, J., Bo, R., Ye, M., Huang, L., Chen, H., & Rui, W. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.04.055 · Cited by 106
Kreiner, F. F., Kraaijenhof, J. M., von Herrath, M., Hovingh, G. K., & von Scholten, B. J. (2022) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2022.2045952 · Cited by 127
“Highlighting the duality of the cytokine, however, it has long been suggested that systemic chronic inflammation mediated via pro-inflammatory cytokines such as IL-6 is central in the pathophysiology of T2D (Figure 2) [35,36].”
BackgroundHall, B. E., Macdonald, E., Cassidy, M. M., Yun, S., Sapio, M. R., Ray, P. R., Doty, M. E., Nara, P., Burton, M. D., Shiers, S. I., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-08100-8 · Cited by 116
Amino-acid sensing and degrading pathways in immune regulation
Grohmann, U., Mondanelli, G., Belladonna, M. L., Orabona, C., Pallotta, M. T., Iacono, A., Puccetti, P., & Volpi, C. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.05.004 · Cited by 117
Dietary AGEs as Exogenous Boosters of Inflammation
Garay‐Sevilla, M. E., Rojas, A., Portero‐Otín, M., & Uribarri, J. (2021) · Nutrients · doi:10.3390/nu13082802 · Cited by 118
Riaz, T. A., Junjappa, R. P., Handigund, M., Ferdous, J., Kim, H., & Chae, H. (2020) · Cells · doi:10.3390/cells9051160 · Cited by 119
“Excess accumulation of fat in different tissues integrates the metabolism and inflammation, causes chronic low-grade inflammation or metaflammation majorly in metabolic tissue, and then causes problems in multiple sites [218].”
BackgroundThe Nlrp3 inflammasome as a “rising star” in studies of normal and malignant hematopoiesis
Ratajczak, M. Z., Bujko, K., Cymer, M., Thapa, A., Adamiak, M., Ratajczak, J., Abdel-Latif, A. K., & Kucia, M. (2020) · Leukemia · doi:10.1038/s41375-020-0827-8 · Cited by 102
Anti-Inflammatory Strategies Targeting Metaflammation in Type 2 Diabetes
Kuryłowicz, A., & Koźniewski, K. (2020) · Molecules · doi:10.3390/molecules25092224 · Cited by 99
“All of these processes result in the increased expression of genes encoding cytokines, chemokines, and adhesion molecules in the peripheral tissues what subsequently attracts infiltrating immune cells that additionally contribute to the synthesis of pro-inflammatory mediators impairing tissue function and in this way…”
BackgroundThe pathophysiology of MASLD: an immunometabolic perspective
Schwärzler, J., Grabherr, F., Grander, C., Adolph, T. E., & Tilg, H. (2023) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2023.2294046 · Cited by 117
“The exact interplay of VAT and liver tissue remains unresolved, but evidence indicates that metabolites derived from the VAT trigger metabolic dysregulation, like insulin resistance and DNL, in hepatocytes [20].”
Nutrition, the visceral immune system, and the evolutionary origins of pathogenic obesity
West-Eberhard, M. J. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1809046116 · Cited by 98
The metabolism-modulating activity of IL-17 signaling in health and disease
Bechara, R., McGeachy, M. J., & Gaffen, S. L. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20202191 · Cited by 104
“Like IL-17, the effects of IL-6 on glucose metabolism are context dependent, leading to both positive (improved insulin sensitivity) and negative (impaired glucose tolerance) outcomes (Hotamisligil, 2017b).”
BackgroundResultInfluentialAccelerated waning of the humoral response to COVID-19 vaccines in obesity
van der Klaauw, A. A., Horner, E. C., Gerber, P. P., Agrawal, U., Foster, W. S., Spencer, S., Vergese, B., Smith, M., Henning, E., Ramsay, I. D., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02343-2 · Cited by 117
Liu, Z., Wang, N., Ma, Y., & Wen, D. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00390 · Cited by 108
“Obesity is often accompanied by chronic low-grade inflammation, disorders of glucose and lipid homeostasis, and metabolic diseases such as type 2 diabetes, cardiovascular disease, and hepatic steatosis (Hotamisligil, 2017).”
BackgroundThe Immune Functions of α1Acid Glycoprotein
Ceciliani, F., & Lecchi, C. (2019) · Current Protein & Peptide Science · doi:10.2174/1389203720666190405101138 · Cited by 98
Lipid Metabolism and Cancer Immunotherapy: Immunosuppressive Myeloid Cells at the Crossroad
Bleve, A., Durante, B., Sica, A., & Consonni, F. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165845 · Cited by 111
“Further, the systemic deregulation of lipid metabolism in obese subjects appears increasingly relevant in modulating cancer-related inflammation [26], expansion of myeloid cells and inflammatory phenotypes [27,28].”
BackgroundValenti, D., Vacca, R. A., Moro, L., & Atlante, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158312 · Cited by 104
The Intestinal Barrier Dysfunction as Driving Factor of Inflammaging
Untersmayr, E., Brandt, A., Koidl, L., & Bergheim, I. (2022) · Nutrients · doi:10.3390/nu14050949 · Cited by 112
“A similar concept is metaflammation, describing a metabolically driven inflammation caused by nutrient excess (for an overview, see [9]).”
BackgroundA temporal perspective for tumor-associated macrophage identities and functions
Blériot, C., Dunsmore, G., Alonso‐Curbelo, D., & Ginhoux, F. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.04.002 · Cited by 112
Type 2 diabetes – An autoinflammatory disease driven by metabolic stress
Gonzalez, L. L., Garrie, K., & Turner, M. D. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.08.034 · Cited by 110
Autoantibody Production in Obesity: Is There Evidence for a Link Between Obesity and Autoimmunity?
Tsigalou, C., Vallianou, N. G., & Dalamaga, Μ. (2020) · Current Obesity Reports · doi:10.1007/s13679-020-00397-8 · Cited by 111
Adipocyte Ceramides—The Nexus of Inflammation and Metabolic Disease
Chaurasia, B., Talbot, C. L., & Summers, S. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.576347 · Cited by 106
“Emerging studies suggest that these fatty acids fuel production of deleterious lipid metabolites such as ceramides while inducing chronic inflammation (3, 6, 14, 15).”
BackgroundGong, F., Yang, N., Wang, Y., Zhuo, M., Zhao, Q., Wang, S., Li, Y., Liu, Z., Chen, Q., & Cheng, L. (2020) · Small · doi:10.1002/smll.202003496 · Cited by 99
Guria, S., Hoory, A., Das, S., Chattopadhyay, D., & Mukherjee, S. (2023) · Bioscience Reports · doi:10.1042/bsr20220200 · Cited by 118
The Interplay of Lipids, Lipoproteins, and Immunity in Atherosclerosis
Pirillo, A., Bonacina, F., Norata, G. D., & Catapano, A. L. (2018) · Current Atherosclerosis Reports · doi:10.1007/s11883-018-0715-0 · Cited by 101
Aamir, K., Khan, H. U., Sethi, G., Hossain, M. A., & Arya, A. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104602 · Cited by 100
Maurya, R., Sebastian, P., Namdeo, M., Devender, M., & Gertler, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.649359 · Cited by 108
Inflammatory Trajectory of Type 2 Diabetes: Novel Opportunities for Early and Late Treatment
Pellegrini, V., Grotta, R. L., Carreras, F., Giuliani, A., Sabbatinelli, J., Olivieri, F., Berra, C., Ceriello, A., & Prattichizzo, F. (2024) · Cells · doi:10.3390/cells13191662 · Cited by 117
Interleukin‐35 in immune‐related diseases: protection or destruction
Zhang, J., Zhang, Y., Wang, Q., Li, C., Deng, H., Si, C., & Xiong, H. (2019) · Immunology · doi:10.1111/imm.13044 · Cited by 100
Zhang, X., Zhang, N., Kan, J., Sun, R., Tang, S., Wang, Z., Chen, M., Liu, J., & Jin, C. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.03.111 · Cited by 105
The Peripheral Immune System and Amyotrophic Lateral Sclerosis
McCombe, P. A., Lee, J. D., Woodruff, T. M., & Henderson, R. D. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00279 · Cited by 96
Organ System Crosstalk in Cardiometabolic Disease in the Age of Multimorbidity
Oishi, Y., & Manabe, I. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00064 · Cited by 101
Periodontitis and metabolic diseases (diabetes and obesity): Tackling multimorbidity
Marruganti, C., Suvan, J. E., & D’Aiuto, F. (2023) · Periodontology 2000 · doi:10.1111/prd.12536 · Cited by 123
Nuclear receptors linking metabolism, inflammation, and fibrosis in nonalcoholic fatty liver disease
Puengel, T., Liu, H., Guillot, A., Heymann, F., Tacke, F., & Peiseler, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052668 · Cited by 95
“For instance, macrophages were identified as key drivers in the regulation of inflammationassociated insulin signaling [20,21].”
BackgroundZhao, X.-L., Yu, L., Zhang, S.-D., Ping, K., Ni, H.-Y., Qin, X.-Y., Zhao, C.-J., Wang, W., Efferth, T., & Fu, Y.-J. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106436 · Cited by 92
Sharma, V., & Mehdi, M. M. (2023) · Neurochemistry International · doi:10.1016/j.neuint.2023.105490 · Cited by 110
Metabolism-Associated Molecular Patterns (MAMPs)
Wang, X., Wang, Y., Antony, V., Sun, H., & Liang, G. (2020) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2020.07.001 · Cited by 103
The ambiguous role of obesity in oncology by promoting cancer but boosting antitumor immunotherapy
Assumpção, J. A. F., Pasquarelli-do-Nascimento, G., Viegas, M. S., Bonamino, M., & Magalhães, K. G. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00796-0 · Cited by 100
“It is worth to note that TNF-α also contributes to insulin resistance in overall obesity, altering the metabolic landscape [315].”
BackgroundInfluentialFatty acids and osteoarthritis: different types, different effects
Loef, M., Schoones, J. W., Kloppenburg, M., & Ioan‐Facsinay, A. (2018) · Joint Bone Spine · doi:10.1016/j.jbspin.2018.07.005 · Cited by 102
“There is evidence indicating that chronic nutrient excess results in increased inflammation through cytokines such as tumour necrosis factor (TNF) and cellular receptors such as toll-like receptor (TLR)-4, and these might be have an important contribution to the pathogenesis of metabolic diseases [20].”
BackgroundMolière, S., Jaulin, A., Tomasetto, C.-L., & Dali-Youcef, N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310649 · Cited by 92
“The paracrine crosstalk between macrophages and adipocytes is notoriously known to promote insulin resistance mediated by metaflammation [51,66].”
BackgroundSignaling pathways and intervention for therapy of type 2 diabetes mellitus
Cao, R. Y., Tian, H., Zhang, Y., Liu, G., Xu, H., Rao, G., Tian, Y., & Fu, X. (2023) · MedComm · doi:10.1002/mco2.283 · Cited by 108
Impact of Sex Differences and Diabetes on Coronary Atherosclerosis and Ischemic Heart Disease
Madonna, R., Balistreri, C. R., Rosa, S. D., Muscoli, S., Selvaggio, S., Selvaggio, G., Ferdinandy, P., & Caterina, R. D. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8010098 · Cited by 106
“Among the AAASP molecules, proinflammatory cytoki es and chemokines, and the monocyte chemoattractant protein (MCP-1), contribute to evocate a strong local inflammatory state, and increase the low-grade systemic inflammation [50,51].”
BackgroundInfluentialEpicardial Adipose Tissue and Cardiovascular Disease
Jemtel, T. H. L., Samson, R., Ayinapudi, K., Singh, T., & Oparil, S. (2019) · Current Hypertension Reports · doi:10.1007/s11906-019-0939-6 · Cited by 99
A Review of Anti-Inflammatory Compounds from Marine Fungi, 2000–2018
Xu, J., Yi, M., Ding, L., & He, S. (2019) · Marine Drugs · doi:10.3390/md17110636 · Cited by 91
“At the same time, it will cause excessive expression of various inflammatory media to produce conditions conducive to many chronic diseases occurrence such as cancer, neurodegenerative disorders, diabetes, and cardiovascular diseases [4,5].”
BackgroundcGAS-STING pathway as a potential trigger of immunosenescence and inflammaging
Schmitz, C. R. R., Maurmann, R. M., Guma, F. T. C. R., Bauer, M. E., & Barbé‐Tuana, F. M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1132653 · Cited by 105
“In addition, the chronic inflammation observed in these disorders equally contributes to a systemic physiological decline similarly observed in the elderly, reinforcing the deleterious effect of this phenomenon per se (91, 95).”
BackgroundAdipocytes in Breast Cancer, the Thick and the Thin
Rybińska, I., Agresti, R., Trapani, A., Tagliabue, E., & Triulzi, T. (2020) · Cells · doi:10.3390/cells9030560 · Cited by 102
“The previous lack of attention can be partially explained by the fact that adipose tissue (AT) used to be regarded as a rather inert site principally storing energy in the form of lipids and cushioning the body [2].”
BackgroundMa, X., Ma, X., Wang, Y., Qiu, G., & Zhang, C. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02869-4 · Cited by 97
“Notably, evidence suggests a significant interactive effect between inflammation and IR [13], implying that single-marker assessments may have biological pathway bias.”
Obesity: pathophysiology and therapeutic interventions
Kong, Y., Yang, H., Nie, R., Zhang, X., Zuo, F., Zhang, H., & Nian, X. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00264-9 · Cited by 89
“This shift results in the formation of dysfunctional and inflammatory adipocytes, accompanied by the recruitment of immune cells into the stromal vascular compartment [93].”
Chen, Y., Guan, M., Wang, R. L., & Wang, X. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1298345 · Cited by 93
Quarta, C., Clemmensen, C., Zhu, Z., Yang, B. S., Joseph, S. S., Lutter, D., Yi, C., Graf, E., García‐Cáceres, C., Legutko, B., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.08.023 · Cited by 93
“The complexity and redundancy of chronic metabolic inflammation necessitates the use of multiacting, combinatorial therapies that engage multiple meta-inflammatory components (Hotamisligil, 2017).”
Backgroundde Azúa, I. R., & Lutz, B. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2994-6 · Cited by 95
Shabani, M., Sadeghi, A., Hosseini, H., Teimouri, M., Khorzoughi, R. B., Pasalar, P., & Meshkani, R. (2020) · Scientific Reports · doi:10.1038/s41598-020-60185-1 · Cited by 99
Mesenchymal stem cells in osteoarthritis therapy: a review.
Zhu, C., Wu, W., & Qu, X. (2021) · American Journal of Translational Research · Cited by 141
Diet-dependent regulation of TGFβ impairs reparative innate immune responses after demyelination
Bosch-Queralt, M., Cantuti-Castelvetri, L., Damkou, A., Schifferer, M., Schlepckow, K., Alexopoulos, I., Lütjohann, D., Klose, C., Vaculčiaková, L., Masuda, T., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00341-7 · Cited by 88
Dietary Interventions to Modulate the Gut Microbiome—How Far Away Are We From Precision Medicine
De Filippis, F., Vitaglione, P., Cuomo, R., Berni Canani, R., & Ercolini, D. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy080 · Cited by 89
Lenighan, Y. M., McNulty, B. A., & Roche, H. M. (2019) · Proceedings of The Nutrition Society · doi:10.1017/s0029665118002793 · Cited by 100
“The activation of the Toll-like receptor 4 (TLR4) pathway and subsequently the NF-κB pathway has been one of the fundamental pathways thought to be involved in SFA-induced inflammation and insulin resistance((74,77)).”
Min, B.-K., Park, S., Kang, H., Kim, D. W., Ham, H. J., Ha, C., Choi, B.-J., Lee, J. Y., Oh, C. J., Yoo, E. K., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00944 · Cited by 101
“Chronic low-grade inflammation in multiple organs increases the risk of developing obesity, diabetes, cardiovascular diseases, and cancers, indicating a major role for the immune system in the etiology of metabolic disorders (5).”
BackgroundGao, H., Luo, Z., Ji, Y., Tang, K., Jin, Z., Ly, C., Sears, D. D., Mahata, S. K., & Ying, W. (2022) · Nature Communications · doi:10.1038/s41467-022-28239-2 · Cited by 97
Chen, G., Chen, H., Ren, S., Xia, M., Zhu, J., Liu, Y., Zhang, L., Tang, L., Sun, L., Liu, H., et al. (2019) · Kidney International · doi:10.1016/j.kint.2019.02.020 · Cited by 92
Role of adipose tissue macrophages in obesity-related disorders
Chakarov, S., Blériot, C., & Ginhoux, F. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20211948 · Cited by 97
“These various cytokines in turn amplify and sustain meta-inflammation by further recruiting, activating, and inducing macrophage proliferation and thereby driving glucose, lipid, and energy metabolic dysregulation (Hotamisligil, 2017; Reilly and Saltiel, 2017).”
Backgroundvan den Bosch, M. H. J., Blom, A. B., & van der Kraan, P. M. (2023) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2023.12.005 · Cited by 91
Lipid scavenging macrophages and inflammation
Vogel, A., Brunner, J. S., Hajto, A., Sharif, O., & Schabbauer, G. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2021.159066 · Cited by 105
Intercepting the Lipid-Induced Integrated Stress Response Reduces Atherosclerosis
Onat, U. I., Yildirim, A. D., Tufanli, Ö., Çimen, I., Kocatürk, B., Veli, Z., Hamid, S. M., Shimada, K., Chen, S., Sin, J., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.12.055 · Cited by 85
Pro-inflammatory Cytokines and Osteocytes
Zhou, M., Li, S., & Pathak, J. L. (2019) · Current Osteoporosis Reports · doi:10.1007/s11914-019-00507-z · Cited by 92
Is diabetes mellitus a risk factor for COronaVIrus Disease 19 (COVID-19)?
Pugliese, G., Vitale, M., Resi, V., & Orsi, E. (2020) · Acta Diabetologica · doi:10.1007/s00592-020-01586-6 · Cited by 97
Benameur, T., Soleti, R., & Porro, C. (2021) · Nutrients · doi:10.3390/nu13041318 · Cited by 82
Epigenetic reprogramming of immune cells in injury, repair, and resolution
Placek, K., Schultze, J. L., & Aschenbrenner, A. C. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124619 · Cited by 91
NAFLD and Cardiovascular Diseases: Epidemiological, Mechanistic and Therapeutic Considerations
Niederseer, D., Wernly, B., Aigner, E. S., Stickel, F., & Datz, C. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10030467 · Cited by 93
Martemucci, G., Fracchiolla, G., Muraglia, M., Tardugno, R., Dibenedetto, R. S., & D‘Alessandro, A. G. (2023) · Antioxidants · doi:10.3390/antiox12122091 · Cited by 99
“Dysfunction of the intestinal barrier linked to dysbiosis promotes intestinal diseases [438,439], while numerous immune disorders can result from commensal dysbiosis [327,440], such as inflammatory bowel disease (IBD) [441], rheumatoid arthritis [442], cardiometabolic diseases [443] and cancer [444].”
Hong, X., Zhou, Y. M., Zhu, Z., Li, Y., Zuo, L., Zhang, Y., Hu, X., Zhu, F., Wang, Y., Fang, M., et al. (2023) · Environment International · doi:10.1016/j.envint.2023.107759 · Cited by 86
Adipokines in obesity and metabolic-related-diseases
Pestel, J., Blangero, F., Watson, J., Pirola, L., & Eljaafari, A. (2023) · Biochimie · doi:10.1016/j.biochi.2023.04.008 · Cited by 77
The cause–effect relation of tuberculosis on incidence of diabetes mellitus
Bisht, M. K., Dahiya, P., Ghosh, S., & Mukhopadhyay, S. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1134036 · Cited by 102
Impact of climate change on immune responses and barrier defense
Skevaki, C. L., Nadeau, K. C., Rothenberg, M. E., Alahmad, B., Mmbaga, B. T., Masenga, G. G., Sampath, V., Christiani, D. C., Haahtela, T., & Renz, H. E. (2024) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2024.01.016 · Cited by 85
Moreno‐Navarrete, J. M., & Fernández‐Real, J. M. (2017) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2017.10.025 · Cited by 87
Field, R., Pourkazemi, F., Turton, J. L., & Rooney, K. B. (2020) · Pain Medicine · doi:10.1093/pm/pnaa378 · Cited by 87
Komleva, Y. K., Chernykh, A., Lopatina, O. L., Gorina, Y. V., Lokteva, I., Salmina, A. B., & Gollasch, M. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.618395 · Cited by 88
“The various effects of CR on metainflammation, IR, and neurodegeneration have been described (Hotamisligil, 2017; Epel, 2020).”
BackgroundVillarreal-Calderón, J. R., Cuellar-Támez, R. X., Castillo, E. C., Ceron, E. L., García‐Rivas, G., & Elizondo‐Montemayor, L. (2021) · Scientific Reports · doi:10.1038/s41598-021-91393-y · Cited by 89
Hypothalamic inflammation in metabolic disorders and aging
Bhusal, A., Rahman, M. H., & Suk, K. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-04019-x · Cited by 94
PUFA-Induced Metabolic Enteritis as a Fuel for Crohn’s Disease
Schwärzler, J., Mayr, L., Vila, A. V., Grabherr, F., Niederreiter, L., Philipp, M., Grander, C., Meyer, M., Jukic, A., Tröger, S., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.01.004 · Cited by 88
Rejeski, K., Jain, M. D., & Smith, E. L. (2023) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2023.04.007 · Cited by 93
Petkevicius, K., Virtue, S., Bidault, G., Jenkins, B., Çubuk, C., Morgantini, C., Aouadi, M., Dopazo, J., Serlie, M. J. M., Koulman, A., et al. (2019) · eLife · doi:10.7554/elife.47990 · Cited by 81
Metadata
- Authors
- Hotamisligil, G. S.
- Venue
- Nature
- Published
- 2017-02-09
- Volume
- 542
- Issue
- 7640
- Pages
- 177-185
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2587680743
- Cited by
- 2,570
- References
- 144
- Citations by year
- 2026: 501 · 2025: 322 · 2024: 264 · 2023: 253 · 2022: 252 · 2021: 296 · 2020: 283 · 2019: 217 · 2018: 125 · 2017: 57
- FWCI
- 24.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institute for Health and Care Research
- Servier
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL125753)
- National Institute of Allergy and Infectious Diseases (R01AI116901)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK052539)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- inflammation, metabolic inflammation, immunometabolism, obesity, metabolic disorders, adipose tissue inflammation, non-communicable diseases, diabetes mellitus
- MeSH terms
- Animals, Clinical Trials as Topic, Hormones, Humans, Inflammation, Invertebrates, Metabolic Diseases, Obesity, Organelles, Signal Transduction, Cytokines, Evolution, Molecular, Genome-Wide Association Study, Adaptive Immunity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.